![Mart Saarma](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mart Saarma
Nessuna posizione attualmente
Storia della carriera di Mart Saarma
Precedenti posizioni note di Mart Saarma
Società | Posizione | Inizio | Fine |
---|---|---|---|
Hermo Pharma Oy
![]() Hermo Pharma Oy Pharmaceuticals: MajorHealth Technology Hermo Pharma Ltd. is a biopharmaceutical company which aims to discover and develop cutting-edge therapeutic approaches for currently untreatable medical needs, particularly in the field of neurology. The company's R&D programs are based on scientifically innovative concepts. These concepts are being developed through preclinical and early clinical development phases with the aim gaining partners prior to late clinical development phases and finally marketing. The company was founded in 2008 by professors Mart Saarma, Eero Castrén, Heikki Rauvala and Dr. Henri Huttunen. The company operates in close collaboration with several academic laboratories affiliated with the University of Helsinki. Hermo Pharma Ltd. operates according to the 'virtual business model'. This means the company outsources the majority of business functions outside of its core business areas, while controlling the key technology assets and strategic partnerships with a small but highly capable group of people managing operations. As the company's overheads are kept lower than traditional biopharmaceutical companies much more of its financial resources can be utilized directly to achieve business goals. Hermo Pharma Ltd. is a privately owned, venture capital backed company. Its current investors include Helsinki University Funds and Seed Fund Vera Ltd. | Direttore/Membro del Consiglio | 01/11/2013 | 13/05/2014 |
HERANTIS PHARMA OYJ | Fondatore | 01/01/2008 | - |
Mobidiag Oy
![]() Mobidiag Oy Miscellaneous Commercial ServicesCommercial Services Mobidiag Oy provides molecular diagnostic for infectious diseases. It develops and provides microarray-based Prove-it technology for early and diagnosis of life-threatening pathogenic microbes causing severe infections. Its Amplidiag product line comprises products for gastrointestinal pathogens and utilizes quantitative real-time polymerase chain reaction technology. The company was founded by Mart Saarma in 2000 and is headquartered in Espoo, Finland. | Direttore/Membro del Consiglio | 01/01/2001 | - |
Fondatore | 01/01/2001 | - |
Formazione di Mart Saarma
University of Tartu | Doctorate Degree |
Statistiche
Distribuzione geografica
Finlandia | 4 |
Estonia | 2 |
Posizioni
Director/Board Member | 2 |
Founder | 2 |
Doctorate Degree | 1 |
Settori
Health Technology | 3 |
Commercial Services | 2 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
HERANTIS PHARMA OYJ | Health Technology |
Aziende private | 2 |
---|---|
Mobidiag Oy
![]() Mobidiag Oy Miscellaneous Commercial ServicesCommercial Services Mobidiag Oy provides molecular diagnostic for infectious diseases. It develops and provides microarray-based Prove-it technology for early and diagnosis of life-threatening pathogenic microbes causing severe infections. Its Amplidiag product line comprises products for gastrointestinal pathogens and utilizes quantitative real-time polymerase chain reaction technology. The company was founded by Mart Saarma in 2000 and is headquartered in Espoo, Finland. | Commercial Services |
Hermo Pharma Oy
![]() Hermo Pharma Oy Pharmaceuticals: MajorHealth Technology Hermo Pharma Ltd. is a biopharmaceutical company which aims to discover and develop cutting-edge therapeutic approaches for currently untreatable medical needs, particularly in the field of neurology. The company's R&D programs are based on scientifically innovative concepts. These concepts are being developed through preclinical and early clinical development phases with the aim gaining partners prior to late clinical development phases and finally marketing. The company was founded in 2008 by professors Mart Saarma, Eero Castrén, Heikki Rauvala and Dr. Henri Huttunen. The company operates in close collaboration with several academic laboratories affiliated with the University of Helsinki. Hermo Pharma Ltd. operates according to the 'virtual business model'. This means the company outsources the majority of business functions outside of its core business areas, while controlling the key technology assets and strategic partnerships with a small but highly capable group of people managing operations. As the company's overheads are kept lower than traditional biopharmaceutical companies much more of its financial resources can be utilized directly to achieve business goals. Hermo Pharma Ltd. is a privately owned, venture capital backed company. Its current investors include Helsinki University Funds and Seed Fund Vera Ltd. | Health Technology |
- Borsa valori
- Insiders
- Mart Saarma
- Esperienza